Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke (CLEVER)

NCT05175547 is registered in ClinicalTrials.gov with ProMedica Health System as lead sponsor.

NCT NCT05175547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke (CLEVER)
Lead sponsor
ProMedica Health System
Phase
Phase 3
Overall status
Completed
Start date
October 30, 2021
Completion date
February 28, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, mechanical thrombectomy, stroke, acute